223 related articles for article (PubMed ID: 21963848)
1. Myc, Aurora Kinase A, and mutant p53(R172H) co-operate in a mouse model of metastatic skin carcinoma.
Torchia EC; Caulin C; Acin S; Terzian T; Kubick BJ; Box NF; Roop DR
Oncogene; 2012 May; 31(21):2680-90. PubMed ID: 21963848
[TBL] [Abstract][Full Text] [Related]
2. A genetic variant of Aurora kinase A promotes genomic instability leading to highly malignant skin tumors.
Torchia EC; Chen Y; Sheng H; Katayama H; Fitzpatrick J; Brinkley WR; Caulin C; Sen S; Roop DR
Cancer Res; 2009 Sep; 69(18):7207-15. PubMed ID: 19738056
[TBL] [Abstract][Full Text] [Related]
3. Cdkn2a suppresses metastasis in squamous cell carcinomas induced by the gain-of-function mutant p53(R172H).
Li Z; Gonzalez CL; Wang B; Zhang Y; Mejia O; Katsonis P; Lichtarge O; Myers JN; El-Naggar AK; Caulin C
J Pathol; 2016 Oct; 240(2):224-34. PubMed ID: 27447534
[TBL] [Abstract][Full Text] [Related]
4. Chronic ultraviolet exposure-induced p53 gene alterations in Sencar mouse skin carcinogenesis model.
Tong Y; Smith MA; Tucker SB
J Toxicol Environ Health; 1997 Jun; 51(3):219-34. PubMed ID: 9183379
[TBL] [Abstract][Full Text] [Related]
5. ROCK2/ras
Masre SF; Rath N; Olson MF; Greenhalgh DA
Oncogene; 2017 May; 36(18):2529-2542. PubMed ID: 27991921
[TBL] [Abstract][Full Text] [Related]
6. PHLDA3 Is an Important Downstream Mediator of p53 in Squamous Cell Carcinogenesis.
Saito M; Sada A; Fukuyo M; Aoki K; Okumura K; Tabata Y; Chen Y; Kaneda A; Wakabayashi Y; Ohki R
J Invest Dermatol; 2022 Apr; 142(4):1040-1049.e8. PubMed ID: 34592332
[TBL] [Abstract][Full Text] [Related]
7. Positive immunohistochemical staining of p53 and cyclin D in advanced mouse skin tumors, but not in precancerous lesions produced by benzo[a]pyrene.
Mitsunaga SI; Zhang SY; Ruggeri BA; Gimenez-Conti I; Robles AI; Conti CJ; Klein-Szanto AJ
Carcinogenesis; 1995 Jul; 16(7):1629-35. PubMed ID: 7542177
[TBL] [Abstract][Full Text] [Related]
8. Considerations for skin carcinogenesis experiments using inducible transgenic mouse models.
Popis MC; Wagner RE; Constantino-Casas F; Blanco S; Frye M
BMC Res Notes; 2018 Jan; 11(1):67. PubMed ID: 29361972
[TBL] [Abstract][Full Text] [Related]
9. Occurrence of multipolar mitoses and association with Aurora-A/-B kinases and p53 mutations in aneuploid esophageal carcinoma cells.
Fichter CD; Herz C; Münch C; Opitz OG; Werner M; Lassmann S
BMC Cell Biol; 2011 Apr; 12():13. PubMed ID: 21470402
[TBL] [Abstract][Full Text] [Related]
10. Expression pattern of a gene for a secreted metalloproteinase during late stages of tumor progression.
Ostrowski LE; Finch J; Krieg P; Matrisian L; Patskan G; O'Connell JF; Phillips J; Slaga TJ; Breathnach R; Bowden GT
Mol Carcinog; 1988; 1(1):13-9. PubMed ID: 3151258
[TBL] [Abstract][Full Text] [Related]
11. MYC gene numerical aberrations in actinic keratosis and cutaneous squamous cell carcinoma.
Toll A; Salgado R; Yébenes M; Martín-Ezquerra G; Gilaberte M; Baró T; Solé F; Alameda F; Espinet B; Pujol RM
Br J Dermatol; 2009 Nov; 161(5):1112-8. PubMed ID: 19673870
[TBL] [Abstract][Full Text] [Related]
12. Enhanced sensitivity to tumor growth and development in multistage skin carcinogenesis by transforming growth factor-alpha-induced epidermal growth factor receptor activation but not p53 inactivation.
Shibata MA; Ward JM; Green JE; Merlino G
Mol Carcinog; 1997 Mar; 18(3):160-70. PubMed ID: 9115586
[TBL] [Abstract][Full Text] [Related]
13. The telomere profile distinguishes two classes of genetically distinct cutaneous squamous cell carcinomas.
Leufke C; Leykauf J; Krunic D; Jauch A; Holtgreve-Grez H; Böhm-Steuer B; Bröcker EB; Mauch C; Utikal J; Hartschuh W; Purdie KJ; Boukamp P
Oncogene; 2014 Jul; 33(27):3506-18. PubMed ID: 23955078
[TBL] [Abstract][Full Text] [Related]
14. Genomic landscape of carcinogen-induced and genetically induced mouse skin squamous cell carcinoma.
Nassar D; Latil M; Boeckx B; Lambrechts D; Blanpain C
Nat Med; 2015 Aug; 21(8):946-54. PubMed ID: 26168291
[TBL] [Abstract][Full Text] [Related]
15. Detection of canine oral papillomavirus-DNA in canine oral squamous cell carcinomas and p53 overexpressing skin papillomas of the dog using the polymerase chain reaction and non-radioactive in situ hybridization.
Teifke JP; Löhr CV; Shirasawa H
Vet Microbiol; 1998 Feb; 60(2-4):119-30. PubMed ID: 9646444
[TBL] [Abstract][Full Text] [Related]
16. Manganese superoxide dismutase is a p53-regulated gene that switches cancers between early and advanced stages.
Dhar SK; Tangpong J; Chaiswing L; Oberley TD; St Clair DK
Cancer Res; 2011 Nov; 71(21):6684-95. PubMed ID: 22009531
[TBL] [Abstract][Full Text] [Related]
17. The multi-step process of human skin carcinogenesis: a role for p53, cyclin D1, hTERT, p16, and TSP-1.
Burnworth B; Arendt S; Muffler S; Steinkraus V; Bröcker EB; Birek C; Hartschuh W; Jauch A; Boukamp P
Eur J Cell Biol; 2007 Dec; 86(11-12):763-80. PubMed ID: 17198740
[TBL] [Abstract][Full Text] [Related]
18. Biallelic TP53 gain of function mutations in rapidly progressing solid tumors.
Sande CM; Chang B; Monga V; Bossler AD; Ma D
Cancer Genet; 2018 Apr; 222-223():20-24. PubMed ID: 29666004
[TBL] [Abstract][Full Text] [Related]
19. Alterations of the p53 tumor suppressor gene during mouse skin tumor progression.
Ruggeri B; Caamano J; Goodrow T; DiRado M; Bianchi A; Trono D; Conti CJ; Klein-Szanto AJ
Cancer Res; 1991 Dec; 51(24):6615-21. PubMed ID: 1742735
[TBL] [Abstract][Full Text] [Related]
20. Mutant p53 drives the loss of heterozygosity by the upregulation of Nek2 in breast cancer cells.
Ghaleb A; Padellan M; Marchenko N
Breast Cancer Res; 2020 Dec; 22(1):133. PubMed ID: 33267874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
